1. Payment of 2025 Cash Dividend
- Payment rate: 1.8%/share (VND 180 per share).
- Payment time: 09/06/2026.
- Payment place:
+ Shareholders whose shares have been deposited will receive dividend at the depository members (DMs) where they opened depository accounts.
+ Shareholders whose shares have not been deposited will receive dividend at the Head Office of Hai Duong Pharmaceutical Medical Material Joint Company, No. 102, Chi Lang Street, Thanh Dong Ward, Hai Phong City on working days of the week starting from 09/06/2026. ID cards/Certificate of Share Ownership have to be presented.
2. 2026 Share issuance due to raising share capital from owner's equity
- Execution ratio: 100:35 (shareholders owning 100 shares will receive 35 additionally issued shares).
- Principle of rounding and handling fractional shares: The number of shares issued will be rounded down to the whole number, the fractional shares (if any) will be removed.
For example: Shareholder A owns 175 shares,shareholder A will receive additional issued shares calculated as follows: 175 :100) x 35 = 61.25 shares. Shareholder Nguyen Van A will receive 61 new shares (The fractional shares of 0.25 share will be removed).
- Payment place:
+ Shareholders whose shares have been deposited will receive bonus shares at the depository member where they opened depository account.
+ Shareholders whose shares have not been deposited: The bondholder carries out procedures to receive shares issued to raising share capital from equity at headquater of Hai Duong Pharmaceutical Medical Material Joint Company, No. 102, Chi Lang Street, Thanh Dong Ward, Hai Phong City. Identity Cards/Certificate of Share Ownership  have to be presented.
Coordination details and procedures for corporate action processing for holders of the above securities between VSDC, the Securities registering institution and depository members are specified in the Guideline on corporate action processing for securities holders at VSDC
Hai Duong Pharmaceutical Medical Material Joint Company  and the parties involved in the process of preparing the dossier, documents of corporate action processin are fully responsible before the law for the legality, accuracy, truthfulness and completeness of the dossier; Institutions and individuals participating in the confirmation of records and documents shall be legally responsible within the scope related to such records and documents as prescribed in Clause 1, Article 11a of the Securities Law No. 54/2019/QH14 dated 26/11/2019, supplemented by Clause 4, Article 1 of Law No. 56/2024/QH15 dated 29/11/2024.